TRIB3 and breast carcinoma: Analysis of The Cancer Genome Atlas (TCGA) data with the web-based OncoLnc analysis tool (http://www.oncolnc.org/) found that TRIB3 was an unfavorable prognostic factor in the overall survival of breast cancer patients (Figure 1F, p = 0.000411).